Clinical Trials Directory

Trials / Completed

CompletedNCT04560855

Secure Self-monitoring Through a Combination of Connected Objects: Implementation in COVID-19 Patients Monitored at Home

Status
Completed
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
Withings · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Currently, COVID+ infected patients who are on ambulatory home monitoring self-assess their health status simply by completing questionnaires and measuring their temperature twice a day. The SECURADOM project proposes to facilitate the follow-up of COVID+ or suspected COVID+ infected patients, followed at home, by collecting clinical signs on a telephone application and to monitor physiological safety parameters (respiratory rate, heart rate, temperature, blood pressure, activity) using connected objects developed by the company WITHINGS. This daily monitoring, which can be transmitted by patients to the doctors in charge of their surveillance, will improve the quality and safety of home monitoring.

Conditions

Interventions

TypeNameDescription
DEVICEConnected devices measurementsThe patient has to measure everyday several vital parameters like respiration and heart rate during the night with Withings Sleep, temperature with Withings Thermo, arterial pressure with Withings Tensiometer and physical activity with Withings smartwatch.

Timeline

Start date
2020-09-14
Primary completion
2021-01-12
Completion
2021-05-12
First posted
2020-09-23
Last updated
2021-05-20

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04560855. Inclusion in this directory is not an endorsement.

Secure Self-monitoring Through a Combination of Connected Objects: Implementation in COVID-19 Patients Monitored at Home (NCT04560855) · Clinical Trials Directory